In addition, the action of DUSP10 on cancer, inflammation, and immunity may take place through inactivation of its ‘classical’ targets p38 and JNK, but also through ERK or by directly targeting other proteins like IRF3 in a MAPK-independent manner. Here, MAPK1 is linked to cancer.